Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
ConditionPlasma Cell Disorders
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders
Eligibility criteria
Qualifiers
Diagnosed with POEMS syndrome (newly diagnosed or in remission) or with newly diagnosed multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS), amyloid light chain (AL) amyloidosis or healthy controls from their households
Disqualifiers
Age under 18 years
Pregnancy
Substance abuse
Antibiotics use or gastrointestinal endoscopy in the 3 months prior to the study participation
Trial design
Treatments tested in this trial
- Non-interventional study (observational)
Treatment groups
240 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov